The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy

OBJECTIVES: Various blood inflammatory biomarkers were associated with treatment response and prognosis of non-small cell lung cancer (NSCLC) in previous studies. In this study, we retrospectively evaluated the prognostic role of pretreatment blood inflammatory biomarkers and epidermal growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hui, Wang, Kunlun, Li, Bingxu, Li, Shenglei, Li, Yan, Yuan, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668866/
https://www.ncbi.nlm.nih.gov/pubmed/34917497
http://dx.doi.org/10.3389/fonc.2021.707041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668866/
https://www.ncbi.nlm.nih.gov/pubmed/34917497
http://dx.doi.org/10.3389/fonc.2021.707041

Ejemplares similares